MRK(Merck & Co., Inc.) 的财务报表:医疗保健,综合制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $48.70B | $59.28B | $60.12B | $64.17B | $65.01B |
| 毛利润 | $35.08B | $41.87B | $43.99B | $48.98B | $48.63B |
| 营业利润 | — | — | — | — | — |
| 净利润 | $13.05B | $14.52B | $365.00M | $17.12B | $18.25B |
| 经营现金流 | $13.12B | $19.09B | $13.01B | $21.47B | $16.47B |
| 自由现金流 | $8.67B | $14.71B | $9.14B | $18.10B | $12.36B |
| 摊薄每股收益 | $5.14 | $5.71 | $0.14 | $6.74 | $7.28 |